ATR241220C195000
- 0.00
- 0.000.00%
AptarGroup Newsroom
Astronics Corporation Stock Tumbles on $150M Convertible Senior Notes Offering
Insider Sale: Director at $ATR (ATR) Sells 1,257 Shares
Aptar Digital Health Partners With the University of Geneva to Advance Migraine Research
3 Packaging Stocks to Keep an Eye on Despite Industry Challenges
Do AptarGroup's (NYSE:ATR) Earnings Warrant Your Attention?
Here's Why AptarGroup (ATR) Is a Strong Growth Stock
PTVE or ATR: Which Is the Better Value Stock Right Now?
Aptar Named Among Top 50 of the 'World's Top Companies for Women 2024' by Forbes
Aptar Pharma Enters Into Exclusive Agreement With Cambridge Healthcare Innovations to Commercialize the Quattrii Dry Powder Inhaler Platform
AptarGroup (NYSE:ATR) Has A Pretty Healthy Balance Sheet
Mid-cap Stocks With 'Significant Scope' to Upside – WF
AptarGroup(ATR.US) Officer Sells US$5.09 Million in Common Stock
AptarGroup Insider Sold Shares Worth $5,088,116, According to a Recent SEC Filing
Form 144 | AptarGroup(ATR.US) Officer Proposes to Sell 5.09 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Oct 28, $AptarGroup(ATR.US)$ Officer STEPHAN B TANDA intends to sell 30,000 shares of its common stock on Oct 28, with a total market value of approximately $5.09 million.
Baird Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $185
AptarGroup Is Maintained at Outperform by Baird
AptarGroup Analyst Ratings
Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $185
Strong Growth Prospects in AptarGroup's Pharma Segment Drive Buy Rating Amid Volatility in Beauty Sector
Express News | Aptargroup Inc : Baird Raises Target Price to $185 From $170